Metformin is a dimethyl biguanide oral
anti-hyperglycemic agent. Lactic acidosis due
to metformin is a fatal metabolic condition
that limits its use in patients in poor clinical
condition, consequently reducing the number of patients who benefit from this medication.
In a double blind randomized clinical trial, we
investigated 200 type 2 diabetic patients after
coronary artery bypass surgery in the open
heart ICU of the Mazandaran Heart Center,
and randomly assigned them to equal intervention
and control groups. The intervention
group received regular insulin infusion along
with 2 metformin 500 mg tablets every twelve
hours, while the control group received only
intravenous insulin with 2 placebo tablets
every twelve hours. Lactate level, pH, base
excess, blood glucose and serum creatinine
were measured over five 12 h periods, with
data averaged for each period. The primary
outcome in this study was high lactate levels.
Comparison between the 2 groups was made
by independent Student’s t-test. To compare
changes in multiple measures in each group
and analysis of group interaction, a repeated
measurement ANOVA test was used.
There was no significant difference
between the 2 groups regarding pH, base
excess, or bicarbonate intake (P>0.05). No
patient showed lactic acidosis in either group.
Lactate levels were 23.0 vs 23.4 in the insulinmetformin
and insulin only groups when the
study was started, respectively. At the end of
the study, those levels were 18.7 vs 18.9,
respectively. In addition, the ANOVA repeated
measurement test did not show a significant
difference in terms of changes in the amount
of lactate level between the 2 groups during
the five measurement tests of the study period
(P>0.05).
High-dose metformin (1,000 mg twice daily
with insulin) does not cause lactic acidosis in
type 2 diabetic patients after coronary artery
bypass surgery.
Lactic acidosis, metformin, coronary artery bypass, type 2 diabetes.
Rahman Ghafari, Assistant Professor of Cardiac Surgery, Mazandaran Heart Center, Hazrat Fatima Hospital, Artesh Boulevard, Sari, Mazandaran Province, Iran. Tel. 0098.151.2226262 – Fax: 0098.151.2268915. E-mail: soshah1964@gmail.com
This study was conducted
with the financial support of the Mazandaran
University of Medical Sciences. The contributions
of the staff of the open heart ICU at the
Mazandaran Heart Center, Sari, Iran are sincerely
appreciated. Also, the authors wish to thank all
the study participants for their tremendous cooperation
and support.
2011-05-16

Trending Topic
Sudden cardiac arrest (SCA) in young adults (typically defined as individuals younger than 40 years) has emerged as an important yet under-recognized public health concern. Recent estimates suggest an incidence of approximately 1–4 cases per 100,000 person-years, underscoring the clinical and epidemiological relevance of SCA in this younger population.1 SCA is a life-threatening medical emergency […]
Sudden cardiac arrest (SCA) in young adults (typically defined as individuals younger than 40 years) has emerged as an important yet under-recognized public health concern. Recent estimates suggest an incidence of approximately 1–4 cases per 100,000 person-years, underscoring the clinical and epidemiological relevance ...
Cardiovascular medicine continues to advance at a remarkable pace, driven by innovation, interdisciplinary collaboration and an ever-deepening understanding of disease mechanisms. As patient populations age and chronic conditions become increasingly complex, the field stands at the intersection of precision therapy, ...
The Evolut Low Risk trial (Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement; ClinicalTrials.gov identifier: NCT02701283) provides reassuring evidence that transcatheter aortic valve replacement (TAVR) ...
Cardiovascular disease (CVD) is one of the major causes of morbidity and mortality throughout the world.1,2 While traditional risk factors are managed intensively, many individuals continue to have considerable residual risk, and emerging factors such as inflammatory mediators are being ...
Coronary artery dissection is a common occurrence during lesion preparation and after drug-coated balloon (DCB) inflation.1 Recent DCB studies focusing on coronary dissections have shown a few key findings: Their angiographic incidence varies between 35 and 60%. Non-flow-limiting dissections left untreated had ...
Despite advancements in mortality rates from cardiovascular disease (CVD) over the last 50 years, it remains the leading cause of death for women and the third leading cause for women aged 18 to 44.1 A 2011 report from the American Heart Association (AHA) starkly ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an inexorably progressive and ultimately fatal cardiomyopathy characterized by the deposition of misfolded transthyretin (TTR) in the form of amyloid fibrils within the myocardium.1 Transthyretin amyloid (ATTR) fibrils are insoluble protease-resistant beta-pleated sheets that are ...
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac abnormality characterized by left ventricular hypertrophy and diastolic dysfunction, primarily attributed to mutations in genes that encode sarcomeric proteins.1,2 The disease manifests in two broad phenotypes: obstructive HCM (oHCM), defined by dynamic left ...
Cardiovascular disease (CVD) continues to be the primary cause of mortality and morbidity globally with middle-aged women presenting with additional and possibly, overlooked risk factors.1 Despite several awareness programmes, there remain several gaps in the political education and representation needs ...
Cardiovascular disease (CVD) is a significant cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). An estimated 60–80% of patients with T2DM die of cardiovascular events.1,2 A bidirectional relationship has been noted between heart failure (HF) ...
This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected ...
Infiltrative cardiomyopathies are a diverse group of cardiac diseases caused by the deposition of abnormal substances within the myocardium and include diseases, such as Fabry disease, sarcoidosis and less common genetic diseases, such as Friedreich’s ataxia and Danon disease.1 ...
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.